PEGY
← Back to signals

BMY

STRONG BUY

Bristol-Myers Squibb Company

Health Care

0.21
PEGY ratio
Rank #55
Why This Matters

This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 77.2% annually over 5 years. Attractive dividend yield of 4.3%.

BMY is trading at 17.0x earnings against 77.2% growth + 4.3% yield, giving a PEGY of 0.21. The math suggests the stock is significantly undervalued relative to its growth and income profile.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

  • Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-04-24

Valuation
17.0x
P/E Ratio
Growth
77.2%
5yr EPS
Income
4.3%
Div Yield
PEGY Components
PEGY Score0.21
Denominator81.5%
EPS (TTM)$3.46
Market Data
Price$58.71
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.210.21(-0.01)
Rank
#37#55(18 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only